In the News

Recent Coverage of HMS in the News
September 10, 2012

Massachusetts Eye and Ear and Joslin Diabetes Center will partner on research and clinical care, focusing particularly on people with diabetes-related eye disease, the groups announced yesterday. The center will be led by Lloyd Paul Aiello, HMS professor of ophthalmology at Joslin Diabetes Center. Joan W. Miller, the Henry Willard Williams Professor of Ophthalmology at Massachusetts Eye and Ear Infirmary, is also quoted in the article.

September 10, 2012

Several research teams are working to figure out ways to spur existing follicles—the tiny organs in the skin that give birth to hair—back into action, or to make new, active follicles. Marie Demay, HMS professor of medicine at Massachusetts General Hospital, has led much of the research in this area focusing on vitamin D.

September 10, 2012

This summer, two drugs under development for Alzheimer’s disease were declared failures, ruining the chances of finding a near-term fix for an illness that is ravaging the memories of more than 5 million Americans. Research by Dennis J. Selkoe, the Vincent and Stella Coates Professor of Neurologic Diseases in the Department of Neurology at Brigham and Women’s Hospital; Reisa Sperling, HMS professor of neurology at Brigham and Women’s Hospital; and Rudolph Tanzi, the Joseph P. and Rose F. Kennedy Professor of Child Neurology at Massachusetts General Hospital, is cited.

September 10, 2012

Doctors say there’s no reason for a gluten-free diet unless you have celiac disease or gluten sensitivity. But if you have regular digestive problems, such as recurrent diarrhea, bloating, or abdominal pain, or a history of hives, eczema, or food allergies, you may want to try a gluten-free experiment. Tim Buie, HMS assistant professor of pediatrics at MassGeneral Hospital for Children, is quoted.

September 9, 2012

The first large and comprehensive study of the genetics of a common lung cancer has found that more than half the tumors from that cancer have mutations that might be treated by new drugs that are already in the pipeline or that could be easily developed. Matthew Meyerson, HMS professor of pathology and Bruce Evan Johnson, HMS professor of medicine, both of Dana-Farber Cancer Institute, are authors on the paper.

September 9, 2012

Most students going into medicine imagine that they will have daily contact with their patients; but the reality is that only a minority will end up as primary care physicians, causing what some experts say could be a critical shortage in the United States, where there are long waits in both doctors’ offices and emergency rooms. Russell Phillips, director of the HMS Center for Primary Care and Andrew Morris-Singer, HMS instructor in medicine at Brigham and Women’s Hospital, are quoted.

September 7, 2012

Researchers at Galenea Corp. will share a five-year, $3 million grant from the National Institute of Mental Health (NIMH) with Kevin Spencer of the VA Boston Healthcare System and Harvard Medical School to develop new biomarkers to measure the effectiveness of drugs aimed at schizophrenia.

September 5, 2012

Scientists say they have mapped the underlying regulatory system that switches DNA on and off, potentially spurring a wave of new research into the molecular basis of complex diseases such as Type 1 diabetes. The ENCODE consortium and Bradley Bernstein, HMS associate professor of pathology at Massachusetts General Hospital, are cited. Stephen Elledge, Gregor Mendel Professor of Genetics and of Medicine, is quoted.

Pages

Submit Photo Requests to HMS
To request photos from the HMS Office of Communications and External Relations, click here.

 

Tell us about your awards
Share news of your achievements with the larger HMS community.  Click here.

 

Book Reviews
If you are a faculty member who has published a book recently, click here.